Should Piperacillin-Tazobactam Be Used as Definitive Therapy Against Enterobacteriaceae Harboring Inducible AmpC Β-Lactamases?
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01160-17
Full Text
Open PDFAbstract
Available in full text
Date
August 24, 2017
Authors
Publisher
American Society for Microbiology